Anticancer Compounds

Cancer, in its diverse forms, evades the body's regulatory mechanisms, resulting in tumor growth, metastasis, and the disruption of normal bodily functions. Understanding the interactions of small molecules with cancer cells can help to identify biomarkers for cancer diagnosis, prognosis, and treatment response. Various protein targets and biological pathways play a role in different types of cancer, offering a vast opportunity for the discovery and development of new cancer therapies.

Library of Anticancer compounds, compiled from the latest data within the KEGG database, offers a comprehensive collection of molecules that are intricately linked to specific targets within significant cancer-related pathways, providing valuable insights into their mechanisms and potential therapeutic uses. The database of targets encompasses various oncogenes, tumor suppressor genes, growth factors, and enzymes involved in cancer cell signaling, proliferation, and survival.

 This library includes approved drugs and investigational compounds, offering a valuable resource for research and drug development. It supports the identification of drug candidates and the repurposing of compounds for novel cancer targets.

Related terms: cancer, epoxide hydrolase, A2A, A3 receptor, fatty acid amide hydrolase, acetylcholinesterase, butyrylcholinesterase, carboxylesterase, Janus kinase